Work

PI3K-AKT-mTOR inhibition in cancer immunotherapy, redux

Year: 2017

Type: review

Source: Seminars in Cancer Biology

DOI: 10.1016/j.semcancer.2017.04.015

Authors: Jake S. O’Donnell, Daniela Massi, Michele W.L. Teng, Mario Mandala

Institutions: The University of Queensland, QIMR Berghofer Medical Research Institute, Ospedale Papa Giovanni XXIII

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Ente Cassa di Risparmio di Firenze, Medical Research Council

OpenAlex ID: W2611933383

FWCI: 2.9

Cites: 126

Cited by: 399

Related to: 10